About BTTC Research and Clinical Trials
The BTTC has experienced unparalleled advancements in the research of alternative
treatments of
malignant brain tumors. Subsequently research studies, also
known as
clinical trials
, are being conducted to learn of promising advances
to
cancer
prevention, diagnosis and treatments that are safe and effective.
The BTTC is now concluding the initial steps of its cutting-edge clinical
trials involving
Malignant
glioma
tumor
. Next step: introduce the trials
to the community.
BTTC Research
Malignant
glioma
brain tumor
have the greatest incidence rate in adults,
while the survival rate remains poor. Pre-clinical data suggests alternative
therapy strategies, including a multi-targeted approach, might be more
effective in controlling the tumor and subsequently improving survival.
Learn more about BTTC Research
Open BTTC Clinical Trials
The current treatment of malignant gliomas, the most common brain tumor
in adults, remains challenging and less effective than desired. Several
trials are in the planning stages, but two current BTTC clinical trials
are available for patients. Those trials hope to deliver results that provide
a more effective treatment therapy in controlling the tumor and, ultimately,
increase survival.
Learn more about the Open Clinical Trials